Extensively Drug-Resistant Tuberculosis, Central China, 2007–2009
Dawei Shi, Hui Li, Yuling Zhao, Qiong Jia, Christopher Coulter, Liang Li
1, and Guofeng Zhu
1
Author affiliations: Institute of Pathogen Biology of Chinese Academy of Medical Sciences, Beijing, China (D. Shi, Q. Jia, G. Zhu); Peking Union Medical College, Beijing (D. Shi, Q. Jia, G. Zhu); National Institute for the Control of Pharmaceutical and Biological Products, Beijing (D. Shi); Henan Provincial Centers for Disease Control and Prevention, Zhengzhou, China (H. Li, Y. Zhao); Pathology Queensland, Brisbane, Queensland, Australia (C. Coulter); and Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing (L. Li)
Main Article
Table
Second-line drug resistance patterns for 143 strains of multidrug-resistant tuberculosis, Henan Province, China, 2007–2009*
Drugs |
No. (%) strains |
INH + RIF |
84 (58.7) |
INH + RIF + KAN |
1 (0.7) |
INH + RIF+ CAP |
3 (2.1) |
INH + RIF + KAN + AMI |
1 (0.7) |
INH + RIF+ KAN + CAP |
1 (0.7) |
INH + RIF+ KAN + AMI + CAP |
4 (2.8) |
INH + RIF+ OFX |
31 (21.7) |
INH + RIF + OFX + KAN |
1 (0.7) |
INH + RIF+ OFX + CAP |
2 (1.4) |
INH + RIF+ OFX + KAN + CAP |
3 (2.1) |
INH + RIF+ OFX + KAN + AMI + CAP |
12 (8.4) |
Total |
143 (100%) |
Main Article
Page created: October 15, 2012
Page updated: October 15, 2012
Page reviewed: October 15, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.